Literature DB >> 7356685

Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration.

D L Granger, R R Taintor, J L Cook, J B Hibbs.   

Abstract

Cytotoxic activated macrophages (CM) inhibited the growth of neoplastic L1210 cells in vitro but L1210 cell death was minimal to nonexistent. L1210 cells injured by CM were separated from macrophages and studied in an isolated system. CM-injured L1210 cells had an absolute requirement for glucose or another glycolyzable hexose (mannose or fructose) for at least 40 h after removal from macrophages. If the culture medium lacked sufficient concentration of one of these sugars, CM-injured L1210 cells died within 4 h. Uninjured L1210 cells cultured alone or with peptone-stimulated macrophages had no such requirement and maintained complete viability in hexoseless medium. The hexose requirement of CM-injured L1210 cells could not be fulfilled by other naturally occurring monosaccharides, glucose or mannose derivatives, or substrates that can be oxidized by mitochondria. The concentration requirements for glucose, mannose, and fructose by CM-injured L1210 cells correlated with the concentrations required to support maximal glycolysis of these sugars by other murine ascites cells. A concentration of 2-deoxy-D-glucose which completely inhibited L1210 cell glycolysis also complete prevented the ability of glucose or mannose to maintain viability of CM-injured L1210 cells. Interaction with CM led to inhibition of L1210 cell mitochondrial oxidative phosphorylation. This was supported by the findings that: (a) CM-injured L1210 cells had no Pasteur effect; their rate of aerobic glycolysis was the same as the rate of anaerobic glycolysis of uninjured L1210 cells, (b) Endogenous respiration of CM-injured L1210 cells was 15% of normal. Maximal inhibition of uninjured L1210 cell respiration by a specific mitochondrial poison (oligomycin) was nearly the same (13% of normal). It followed that CM-injured L1210 cells required hexose for chemical energy production via the glycolytic pathway. CM-induced mitochondrial injury occurred in five other neoplastic cell lines tested.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7356685      PMCID: PMC371374          DOI: 10.1172/JCI109679

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.

Authors:  H E SKIPPER; F M SCHABEL; W S WILCOX
Journal:  Cancer Chemother Rep       Date:  1964-02

2.  Effects of lysozyme on normal and transformed mammalian cells.

Authors:  E F Osserman; M Klockars; J Halper; R E Fischel
Journal:  Nature       Date:  1973-06-08       Impact factor: 49.962

Review 3.  Bioenergetics and the problem of tumor growth.

Authors:  E Racker
Journal:  Am Sci       Date:  1972 Jan-Feb       Impact factor: 0.548

4.  Heterocytolysis by macrophages activated by bacillus Calmette-Guérin: lysosome exocytosis into tumor cells.

Authors:  J B Hibbs
Journal:  Science       Date:  1974-04-26       Impact factor: 47.728

5.  Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni.

Authors:  J B Hibbs; L H Lambert; J S Remington
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

6.  Glycolytic and respiratory properties of intact mammalian cells: inhibitor studies.

Authors:  C T Gregg; J M Machinist; W D Currie
Journal:  Arch Biochem Biophys       Date:  1968-09-20       Impact factor: 4.013

7.  The role of activated macrophages in specific and nonspecific cytostasis of tumor cells.

Authors:  J L Krahenbuhl; J S Remington
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

8.  Conditionally lethal mutations in chinese hamster cells. Characterization of a cell line with a possible defect in the Krebs cycle.

Authors:  L DeFrancesco; D Werntz; I E Scheffler
Journal:  J Cell Physiol       Date:  1975-04       Impact factor: 6.384

9.  Cytokinetic studies of the effects of activated macrophages on tumor target cells.

Authors:  J L Krahenbuhl; L H Lambert
Journal:  J Natl Cancer Inst       Date:  1975-06       Impact factor: 13.506

10.  Differential stimulation of murine lymphoma growth in vitro by normal and BCG-activated macrophages.

Authors:  C F Nathan; W D Terry
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

View more
  28 in total

Review 1.  Mechanisms of organ dysfunction in critical illness: report from a Round Table Conference held in Brussels.

Authors:  M P Fink; T W Evans
Journal:  Intensive Care Med       Date:  2002-02-08       Impact factor: 17.440

2.  Inhibition of mitochondrial protein synthesis results in increased endothelial cell susceptibility to nitric oxide-induced apoptosis.

Authors:  Anup Ramachandran; Douglas R Moellering; Erin Ceaser; Sruti Shiva; Jun Xu; Victor Darley-Usmar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

3.  Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication.

Authors:  Y L Lin; Y L Huang; S H Ma; C T Yeh; S Y Chiou; L K Chen; C L Liao
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Cytostatic and cytotoxic effects of activated macrophages and nitric oxide donors on Brugia malayi.

Authors:  G R Thomas; M McCrossan; M E Selkirk
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

5.  Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible.

Authors:  J C Drapier; J B Hibbs
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

6.  Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages.

Authors:  D L Granger; J B Hibbs; J R Perfect; D T Durack
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

7.  Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease.

Authors:  H Kimura; S Miura; T Shigematsu; N Ohkubo; Y Tsuzuki; I Kurose; H Higuchi; Y Akiba; R Hokari; M Hirokawa; H Serizawa; H Ishii
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

8.  Potential role of nitric oxide in the pathophysiology of experimental bacterial meningitis in rats.

Authors:  B L Buster; A C Weintrob; G C Townsend; W M Scheld
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Selection for enhanced adhesion to microvessel endothelial cells or resistance to interferon-gamma modulates the metastatic potential of murine RAW117 large-cell lymphoma cells.

Authors:  R A LaBiche; R J Tressler; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1993-11       Impact factor: 5.150

10.  An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality.

Authors:  M Bianchi; P Ulrich; O Bloom; M Meistrell; G A Zimmerman; H Schmidtmayerova; M Bukrinsky; T Donnelley; R Bucala; B Sherry
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.